The explosion of osteoporosis-related diagnostic
and therapeutic options in the past 6 to 10 years has created its own
challenges. Guidelines have recently been published concerning who
should be tested1 but, in a sense, that issue is moot. Bone
mass measurement technology is proliferating rapidly, and physicians
increasingly are confronted with ostensibly healthy individuals who
bring them a printout showing that they have low bone mass. Should the
physician recommend one of the growing array of bisphosphonates,
selective estrogen receptor modulators, hormone replacement therapy
regimens, or dietary supplements? Normally, the clinician treats the
patient, not a test, but when it comes to prevention, the test result
may be all the physician has to go on.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 15
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
The Rational Clinical Examination
Evidence Summary and Review 2
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.